• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

BELLUS Health Inc

+ Add to Watchlist

BLU:CN

1.1800 CAD 0.1300 12.38%

As of 15:59:36 ET on 07/21/2014.

Snapshot for BELLUS Health Inc (BLU)

Open: 1.1000 Day's Range: 1.0600 - 1.1800 Volume: 38,748
Previous Close: 1.0500 52wk Range: 0.2700 - 1.3000 1-Yr Rtn: +337.04%

Stock Chart for BLU

No chart data available.
  • BLU:CN 1.1400
  • 1D
  • 1M
  • 1Y
1.0500
Interactive BLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLU

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.3000
Est. EPS (CAD) (12/2013) -
Est. PEG Ratio -
Market Cap (M CAD) 55.96
Shares Outstanding (M) 47.43
30 Day Average Volume 33,738
Price/Book (mrq) -
Price/Sale (ttm) 3.8014
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLU

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for BLU

BELLUS Health Inc. develops and commercializes therapeutics for neurological disorders. The Company has products in clinical trials for AA amyloidosis, the treatment of Alzheimer's Disease, and for the prevention of hemorrhagic stroke caused by amyloid angiopathy.

Roberto BelliniPresident/CEODenis GarceauSenior VP:Drug Development
Francois DesjardinsVP:FinanceTony MatzouranisVP:Business Development
More Company Profile & Key Executives for BLU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil